Relmada Therapeutics Inc (RLMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 44,443 | 11,449 | 4,669 | 3,804 | 2,495 |
| Marketable Securities | 167,466 | 76,638 | 104,399 | 98,900 | 114,596 |
| Receivables | 86 | 85 | 83 | 81 | 80 |
| TOTAL | $223,298 | $90,887 | $110,700 | $103,776 | $118,074 |
| Non-Current Assets | |||||
| PPE Net | N/A | N/A | N/A | 1 | 1 |
| Other Non-Current Assets | 28 | 47 | 69 | 90 | 111 |
| TOTAL | $28 | $47 | $69 | $91 | $113 |
| Total Assets | $223,326 | $90,934 | $110,769 | $103,867 | $118,186 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 11,193 | 12,709 | 10,456 | 8,083 | 8,347 |
| Accrued Expenses | 3,868 | 5,539 | 3,461 | 4,637 | 4,257 |
| TOTAL | $15,061 | $18,247 | $13,917 | $12,719 | $12,604 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $15,061 | $18,247 | $13,917 | $12,719 | $12,604 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 29,369 | 17,531 | 17,473 | 16,796 | 16,746 |
| Common Shares | 28 | 18 | 18 | 17 | 16 |
| Retained earnings | -305,067 | -270,689 | -228,082 | -201,531 | -179,315 |
| TOTAL | $208,265 | $72,687 | $96,853 | $91,147 | $105,583 |
| Total Liabilities And Equity | $223,326 | $90,935 | $110,769 | $103,867 | $118,186 |